Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Pin to quick picksYGEN.L Share News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Stocks start second half in green amid PMIs

Mon, 03rd Jul 2023 09:07

(Alliance News) - European markets rose at Monday's open, kicking off the start of the second half on a positive note, boosted by strong trading in Asia and New York,

The FTSE 100 index opened up 18.52 points, 0.3%, at 7,550.05. The FTSE 250 was up 72.89 points, 0.4%, at 18,489.65, and the AIM All-Share was up 0.65 point, 0.1%, at 754.16.

The Cboe UK 100 was up 0.2% at 753.09, the Cboe UK 250 was up 0.3% at 16,141.46, and the Cboe Small Companies was up 0.1% at 13,727.97.

"The FTSE 100 opened marginally higher, helped by the tailwinds of a strong session in Asia and on Wall Street on Friday. But it's still struggling to find significant momentum, dragged down by concerns about growth in China and the wider global economy," commented Hargreaves Lansdown's Susannah Streeter.

In European equities, the CAC 40 in Paris was up 0.2%, while the DAX 40 in Frankfurt was up 0.3%.

Shares in Tesla were up 5.2% in Frankfurt after the US automaker said deliveries in the second quarter beat market estimates.

The electric car maker delivered 466,140 vehicles, an 83% increase year-on-year and above estimates of 450,000.

"The electric vehicle giant has benefitted from US federal credits which are designed to encourage consumers to shift away from diesel and petrol cars," interactive investor's Victoria Scholar said. "Its strategy to cut prices this year has also paid off amid the macroeconomic headwinds but could weigh on profit margins ahead."

Tesla's production is still a long way below that of major car makers such as Toyota, which produced nearly 950,000 vehicles in May alone this year.

In Asia on Monday, markets took their cue from the strong performance on Wall Street, despite some mixed economic data for the region.

The Nikkei 225 index in Tokyo closed up 1.7%, with Toyota up 0.7%.

In China, the Shanghai Composite closed up 1.3%, while the Hang Seng index in Hong Kong was up 2.3%. The S&P/ASX 200 in Sydney closed up 0.6%.

Early economic data pointed towards a slowdown in Asian manufacturing.

The Caixin purchasing managers' index for China's manufacturing indicated marginal growth in June, albeit at a slower pace than in May. Meanwhile, the au Jibun Bank PMI for Japan showed its manufacturing sector slipped back into a slight contraction. Respondents in Japan noted especially weak demand from mainland China, with exports orders continuing to fall.

In the US on Friday, Wall Street ended higher, with the Dow Jones Industrial Average up 0.8%, the S&P 500 up 1.2% and the Nasdaq Composite up 1.5%. Sentiment was lifted by a cooler-than-expected US inflation print, which boosted hopes that the Federal Reserve's rate-rising spree might be close to an end.

Still, the dollar was firm against other major currencies in early exchanges in Europe on Monday.

Sterling was quoted at USD1.2670, lower than USD1.2706 at the London equities close on Friday. The euro traded at USD1.0880, lower from USD1.0916. Against the yen, the dollar was quoted at JPY144.75, up versus JPY144.58.

In London, supermarket chain Tesco rose 0.9% as it named Gerry Murphy as its new chair from September 1.

Murphy is currently chair of luxury fashion firm Burberry and food supplier Tate & Lyle, and will step down from his role at the latter to "ensure he has sufficient capacity" for his new role at Tesco.

Murphy was also previously CEO at Kingfisher, and has held non-executive directorships at companies including British American Tobacco and Reckitt Benckiser.

Shares in Tate & Lyle fell 0.5%, while Buberry was trading flat.

Anglo American rose 2.3%, as it announced late on Friday that its diamond business, de Beers, reached an eleventh-hour deal with the Botswanan government. This followed months of tense negotiations that saw the continent's top producer threatening to cut ties with the storied diamond company.

The Botswana government and Anglo-American, have reached an "agreement in principle", the two sides said in a statement issued late Friday. The agreement provides for a new 10-year agreement to sell the rough diamonds produced by Debswana – a joint venture equally owned by the government and De Beers – and a 25-year extension of its mining licenses.

AstraZeneca fell 5.9% in early trade - the worst large-cap performer - as it announced high-level results from the Tropian-Lung01 phase III trial.

The trial looked at datopotamab deruxtecan, or Dato-DXd, in advanced non-small cell lung cancer. In patients will locally advanced or metastatic NSCLC treated with at last one prior therapy, the treatment showed a "statistically significant" improvement for the dual primary endpoint of progression-free survival compared to docetaxel, the current standard of care chemotherapy.

However, for the dual primary endpoint of overalll survival, the data "were not mature".

"An early trend was observed in favour of datopotamab deruxtecan versus docetaxel that did not meet the prespecified threshold for statistical significance at this interim analysis," AstraZeneca said.

The trial will continue as planned in order to assess OS with greater security.

On AIM, Yourgene Health more than doubled in value, with its shares reaching 0.47 pence from 0.20p on Friday.

The molecular diagnostic group has agreed a cash takeover offer with Novacyt UK, a wholly-owned subsidiary of fellow AIM listing Novacyt. The offer of 0.522p a share values the company at GBP16.7 million.

Novacyt is a biotechnology group focused on clinical diagnostics. Its shares were up 16%.

"The acquisition combines highly complementary technologies and services, with the enlarged group able to leverage mutual research and development capabilities for ongoing product development and portfolio enhancement to improve the customer offering," the companies said.

Gold was quoted at USD1,916.08 an ounce early Monday, higher than USD1,915.48 on Friday. Brent oil was trading at USD75.28 a barrel, little changed from USD75.58

There are more manufacturing PMI readings to come, including the UK at 0930 BST and the US at 1445 BST.

Financial markets in New York close at 1300 local time on Monday for Independence Day. They stay closed on Tuesday for the US public holiday.

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
27 Jul 2022 12:25

Yourgene brings forward new chair's start date as revenue jumps

(Alliance News) - Yourgene Health PLC on Wednesday said that John Brown, who was expected to be promoted to chair in September, will take up the role immediately.

Read more
27 Jul 2022 12:01

EARNINGS UPDATES: Yourgene posts record revenue; Solid State payout up

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
20 Jul 2022 16:05

UK earnings, trading statements calendar - next 7 days

Thursday 21 July  
AJ Bell PLCQ3 Results
Anglo American PLCQ2 Production Results
Brewin Dolphin Holdings PLCTrading Statement
Britvic PLCQ3 Results
Close Brothers Group PLCTrading Statement
Diploma PLCQ3 Results
Dunelm Group PLCTrading Statement
DWF Group PLCFull Year Results
Euromoney Institutional Investor PLCQ3 Results
Frasers Group PLCTrading Statement
Fulham Shore PLCFull Year Results
Howden Joinery Group PLCHalf Year Results
IG Group Holdings PLCFull Year Results
Intermediate Capital Group PLCQ1 Results
Ocado Group PLCHalf Year Results
PensionBee Group PLCTrading Statement
Polymetal International PLCQ2 Production Results
Qinetiq Group PLCTrading Statement
Redcentric PLCFull Year Results
Seraphine Group PLCFull Year Results
SSE PLCQ1 Results
Workspace Group PLCQ1 Results
Friday 22 July  
Beazley PLCHalf Year Results
FRP Advisory Group PLCFull Year Results
Record PLCQ1 Results
Monday 25 July 
ECO Animal Health Group PLCFull Year Results
F&C Investment Trust PLCHalf Year Results
GlobalData PLCHalf Year Results
JTC PLCTrading Statement
Plant Health Care PLCTrading Statement
SThree PLCHalf Year Results
Vodafone Group PLCTrading Statement
XLMedia PLCTrading Statement
Tuesday 26 July 
Aberforth Smaller Companies Trust PLCHalf Year Results
Ascential PLCHalf Year Results
Bytes Technology Group PLCTrading Statement
Capital & Counties Properties PLCHalf Year Results
Cohort PLCFull Year Results
Compass Group PLCTrading Statement
Drax Group PLCHalf Year Results
easyJet PLCTrading Statement
Ergomed PLCTrading Statement
Franchise Brands PLCHalf Year Results
Games Workshop Group PLCFull Year Results
Gore Street Energy Storage Fund PLCFull Year Results
Greencore Group PLCQ3 Results
John Menzies PLCTrading Statement
Medica Group PLCTrading Statement
Mitie Group PLCTrading Statement
NewRiver REIT PLCTrading Statement
Playtech PLCTrading Statement
Reach PLCHalf Year Results
Ricardo PLCTrading Statement
Sabre Insurance Group PLCHalf Year Results
SME Credit Realisation Fund LtdFull Year Results
Trifast PLCFull Year Results
Tyman PLCHalf Year Results
Unilever PLCHalf Year Results
Vivo Energy PLCHalf Year Results
Wickes Group PLCTrading Statement
Wednesday 27 July 
Aptitude Software Group PLCHalf Year Results
Aston Martin Lagonda Global Holdings PLCHalf Year Results
BlackRock Energy & Resources Income Trust PLCHalf Year Results
Breedon Group PLCHalf Year Results
British American Tobacco PLCHalf Year Results
FirstGroup PLCTrading Statement
Fresnillo PLCQ2 Production Results
GSK PLCHalf Year Results
Hargreaves Services PLCFull Year Results
Hiscox LtdTrading Statement
Ibstock PLCHalf Year Results
International Personal Finance PLCHalf Year Results
Lancashire Holdings LtdHalf Year Results
Lloyds Banking Group PLCHalf Year Results
Marston's PLCTrading Statement
Motorpoint Group PLCTrading Statement
musicMagpie PLCHalf Year Results
Nichols PLCHalf Year Results
Primary Health Properties PLCHalf Year Results
Quartix Technologies PLCHalf Year Results
Reckitt Benckiser Group PLCHalf Year Results
Rio Tinto PLCHalf Year Results
Smart Metering Systems PLCHalf Year Results
Smurfit Kappa Group PLCHalf Year Results
Ted Baker PLCTrading Statement
Unite Group PLCHalf Year Results
Wizz Air Holdings PLCQ1 Results
Yourgene Health PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
12 May 2022 15:19

DIRECTOR DEALINGS: Yourgene CEO and Big Technologies CFO buy shares

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Thursday and not separately reported by Alliance News:

Read more
26 Apr 2022 19:17

IN BRIEF: Yourgene Health annual revenue doubles on Covid testing

Yourgene Health PLC - Manchester-based molecular diagnostics - For the year ended March 31, revenue more than doubles year-on-year to GBP37.6 million, with the majority of growth coming from the Genomics Services business on Covid PCR testing and variant sequencing.

Read more
26 Apr 2022 15:51

EXECUTIVE CHANGES: Carnival promotes COO & UK chief Weinstein to CEO

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Tuesday and not separately reported by Alliance News:

Read more
25 Apr 2022 18:04

IN BRIEF: Yourgene Health extends partnership with Ambry Genetics

Yourgene Health PLC - Manchester-based molecular diagnostics company - Extends strategic partnership with US precision medicine firm Ambry Genetics, for a new Genomic Services collaboration. The partnership will give both firms access to each other's technology and assays.

Read more
17 Feb 2022 15:21

Yourgene gets UK approval for 'Clarigene' Covid-19 test

(Sharecast News) - Molecular diagnostic company Yourgene has received confirmation from the UK Health Security Agency that the 'Clarigene' SARS-CoV-2 test has been approved under the requirements set out in the Coronavirus Test Device Approvals regulations, it announced on Thursday.

Read more
17 Feb 2022 12:06

IN BRIEF: Yourgene wins UK approval for Clarigene Covid test

Yourgene Health PLC - Manchester-based molecular diagnostics company - Wins approval for Clarigene Covid test from UK Health Security Agency under the Medical Devices Regulations 2021 as it pertains to new Covid Test Device Approvals. Will be included in government register of approved products. Was achieved after "extended timeline", but did not impact Yourgene revenue which did not rely on Clarigene sales or regulatory approval.

Read more
19 Jan 2022 16:52

TRADING UPDATES: In The Style in fashion; East Imperial toasts US deal

TRADING UPDATES: In The Style in fashion; East Imperial toasts US deal

Read more
18 Jan 2022 15:23

Yourgene signs five-year partnership agreement with EKF Diagnostics

Yourgene signs five-year partnership agreement with EKF Diagnostics

Read more
17 Jan 2022 14:44

IN BRIEF: Yourgene Health expects full-year revenue ahead of guidance

IN BRIEF: Yourgene Health expects full-year revenue ahead of guidance

Read more
17 Jan 2022 12:06

Yourgene Health sees FY revenue, underlying EBITDA ahead of expectations

(Sharecast News) - Molecular diagnostic company Yourgene Health said on Monday that full-year earnings and revenues will exceed expectations after the strong trading performance delivered by the group in the first half of the year continued into the second.

Read more
23 Dec 2021 11:34

Yourgene wins lab contract for Covid-19 testing from UK government

Yourgene wins lab contract for Covid-19 testing from UK government

Read more
23 Dec 2021 09:02

Yourgene wins Covid-19 surge testing support contract with DHSC

(Sharecast News) - Molecular diagnostics group Yourgene has been awarded a contract to provide laboratory capacity to the Department of Health & Social Care in order to support a Winter surge in Covid-19 testing.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.